Q1 2024 Verrica Pharmaceuticals Inc Earnings Call Transcript

May 13, 2024 / 12:30PM GMT
Operator

Ladies and gentlemen, good morning, and welcome to the Verrica Pharmaceuticals first-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Chris Calabrese from LifeSci Advisors. Please go ahead.

Chris Calabrese - LifeSci Advisors - Managing Director

Thank you, operator. Hello, everyone, and welcome to Verrica Pharmaceuticals first-quarter 2024 corporate update and earnings conference call. With me on the line this morning are Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals; Joe, Bonaccorso, Chief Commercial Officer; Terry Kohler, Chief Financial Officer; Dr. Gary Goldenberg, Verrica's Chief Medical Officer; and Chris Hayes, Verrica's Chief Legal Officer.

As a reminder, during today's call, management will make forward looking statements. These statements may include expectations related to the launch and commercialization of Ycanth for the treatment of molluscum contagiousum in the United States. Regulatory developments,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot